Cancer overdiagnosis: a biological challenge and clinical dilemma

S Srivastava, EJ Koay, AD Borowsky… - Nature Reviews …, 2019 - nature.com
For cancer screening to be successful, it should primarily detect cancers with lethal potential
or their precursors early, leading to therapy that reduces mortality and morbidity. Screening …

Metal drugs and the anticancer immune response

B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …

Tertiary lymphoid structures in cancer and beyond

MC Dieu-Nosjean, J Goc, NA Giraldo… - Trends in …, 2014 - cell.com
Tertiary lymphoid structures (TLS) are ectopic lymphoid formations found in inflamed,
infected, or tumoral tissues. They exhibit all the characteristics of structures in the lymph …

The immune system and cancer evasion strategies: therapeutic concepts

S Muenst, H Läubli, SD Soysal… - Journal of internal …, 2016 - Wiley Online Library
The complicated interplay between cancer and the host immune system has been studied
for decades. New insights into the human immune system as well as the mechanisms by …

The non–small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome

R Remark, C Becker, JE Gomez, D Damotte… - American journal of …, 2015 - atsjournals.org
Solid tumors, beyond mere accumulation of cancer cells, form a complex ecosystem
consisting of normal epithelial cells, fibroblasts, blood and lymphatic vessels, structural …

Immunomodulation by ionizing radiation—impact for design of radio‐immunotherapies and for treatment of inflammatory diseases

B Frey, M Rückert, L Deloch, PF Rühle… - Immunological …, 2017 - Wiley Online Library
Ionizing radiation is often regarded as an element of danger. But, danger responses on the
cellular and molecular level are often beneficial with regard to the induction of anti‐tumor …

Immune contexture, immunoscore, and malignant cell molecular subgroups for prognostic and theranostic classifications of cancers

E Becht, NA Giraldo, C Germain, A de Reyniès… - Advances in …, 2016 - Elsevier
The outcome of tumors results from genetic and epigenetic modifications of the transformed
cells and also from the interactions of the malignant cells with their tumor microenvironment …

Exercise and cancer: from “healthy” to “therapeutic”?

M Idorn, P thor Straten - Cancer Immunology, Immunotherapy, 2017 - Springer
Exercise improves functional capacity and patient-reported outcomes across a range of
cancer diagnoses. The mechanisms behind this protection have been largely unknown, but …

In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide

R Remark, T Merghoub, N Grabe, G Litjens… - Science …, 2016 - science.org
Despite remarkable recent achievements of immunotherapy strategies in cancer treatment,
clinical responses remain limited to subsets of patients. Predictive markers of disease …

The evolving role of immune cells in prostate cancer

C Wang, Y Zhang, WQ Gao - Cancer letters, 2022 - Elsevier
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of
cancer-related death among men in western countries. Androgen deprivation therapy (ADT) …